Source:http://linkedlifedata.com/resource/pubmed/id/19800825
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-2-1
|
pubmed:abstractText |
Radiation therapy (RT) to the brain is often used in the treatment of children with different types of malignant diseases affecting the brain. However, RT in childhood may also have severe side effects including impaired brain maturation and intellectual development. For childhood cancer survivors these adverse effects of RT can cause lifelong disability and suffering. Therefore, there is an unmet need to limit late effects after RT. Precursor cells in the subgranular zone of the dentate gyrus (DG) in the hippocampus are particularly sensitive to irradiation (IR). This may be of significance as newly generated neurons in the DG are important for memory and learning. GH secretagogues (GHS) have previously been shown to promote neurogenesis and to have neuroprotective effects. In addition, several parts of the brain, including the hippocampus, have been shown to express the GHS receptor 1a (GHS-R1a). The aim of this study was to evaluate the potential effect of the GHS hexarelin on proliferation and survival of progenitor cells in the hippocampus after brain IR in a mouse model.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Radiation-Protective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/hexarelin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1532-2238
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-54
|
pubmed:dateRevised |
2011-1-12
|
pubmed:meshHeading |
pubmed-meshheading:19800825-Animals,
pubmed-meshheading:19800825-Brain,
pubmed-meshheading:19800825-Cell Proliferation,
pubmed-meshheading:19800825-Cell Survival,
pubmed-meshheading:19800825-Cytoprotection,
pubmed-meshheading:19800825-Dentate Gyrus,
pubmed-meshheading:19800825-Histones,
pubmed-meshheading:19800825-Male,
pubmed-meshheading:19800825-Mice,
pubmed-meshheading:19800825-Mice, Inbred C57BL,
pubmed-meshheading:19800825-Neurogenesis,
pubmed-meshheading:19800825-Neuroprotective Agents,
pubmed-meshheading:19800825-Oligopeptides,
pubmed-meshheading:19800825-Radiation-Protective Agents
|
pubmed:year |
2010
|
pubmed:articleTitle |
The growth hormone secretagogue hexarelin increases cell proliferation in neurogenic regions of the mouse hippocampus.
|
pubmed:affiliation |
Laboratory of Experimental Endocrinology, Department of Internal Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Anna.barlind@medic.gu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|